Moderna

Yahoo Finance • 3 days ago

Report on COVID vaccine benefits being delayed at CDC: WaPo

[CDC Centers for Disease Control and Prevention] The acting director of the Centers for Disease Control and Prevention, Jay Bhattacharya, has delayed the publication of a CDC report indicating that COVID vaccines cut the risk of ER visits... Full story

Yahoo Finance • 4 days ago

Bank of America flags international opportunities as key growth driver for Moderna

Moderna eyes international markets as growth driver, says Bank of America Proactive uses images sourced from Shutterstock Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to highlight progress in international COVID-19 vaccine markets whe... Full story

Yahoo Finance • 5 days ago

Messenger RNA (mRNA) Market Projected to Reach $20.99 Billion by 2035 - Moderna, Pfizer, and Others Propel mRNA Expansion into New Therapeutic Areas

Company Logo Messenger RNA MarketMessenger RNA Market·GlobeNewswire Inc. Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Messenger RNA Market - A Global and Regional Analysis: Application and Regional Analysis - Analysis and Forecast, 20... Full story

Yahoo Finance • 5 days ago

You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.

The first quarter was a difficult one for the S&P 500 and for investors as a variety of concerns circulated -- from worries about the revenue potential of artificial intelligence (AI) companies to the pressures of turmoil in Iran. All of t... Full story

Yahoo Finance • 7 days ago

Jim Cramer Discusses the Moderna Rally and the Impact of FDA Leadership Changes

Moderna, Inc. (NASDAQ:MRNA) is among the stocks in focus as Jim Cramer reviewed the S&P 500’s top performers and the Nasdaq 100’s biggest laggards for the first quarter. Cramer highlighted the bullish environment around the stock, as he sa... Full story

Yahoo Finance • 7 days ago

Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus

Wall Street’s major market averages ended mixed on Thursday as markets assessed President Donald Trump’s address to the nation and the latest developments in the Middle East conflict. The tech-focused Nasdaq Composite finished +0.1%. At t... Full story

Yahoo Finance • 9 days ago

2 S&P 500 Stocks with Exciting Potential and 1 We Ignore

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, decl... Full story

Yahoo Finance • 9 days ago

This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.

Quick Read The State Street SPDR S&P Biotech ETF (XBI) has gained 58% over the past year and trades at $128, with potential for nearly 50 points of upside to reach its 2021 all-time high of $175. Top holdings include Moderna (2.25%), Roiv... Full story

Yahoo Finance • 13 days ago

Advanced Melanoma Markets and Companies 2026-2030: Cumulative Revenue to Grow by $1.87 Billion

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Advanced Melanoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The advanced melanoma market has demonstrated robust growth, expanding from $4.12 billion in 202... Full story

Yahoo Finance • 17 days ago

2 Healthcare Stocks That Could Soar Over the Next 5 Years

Key Points These two biotechs could ride the wave of significant clinical progress. However, both carry above-average risk. 10 stocks we like better than Moderna › While the stock market is facing significant volatility right now, there... Full story

Yahoo Finance • 17 days ago

New TPA Report Finds FDA Costs Soaring, Drug Rejections Rising

WASHINGTON, March 26, 2026 /PRNewswire/ -- Today, the Taxpayers Protection Alliance (TPA) released a report, "Blocking Breakthroughs: Delays and Denials at the FDA," highlighting the many issues with the Food and Drug Administration's (FDA... Full story

Yahoo Finance • 18 days ago

Bernstein Initiates Coverage of Roivant Sciences Ltd. (ROIV) with an Outperform Rating

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 19, 2026, Bernstein initiated coverage of Roivant Sciences Ltd. (NASDAQ:ROIV) with an Outperform rating and a $35 price target,... Full story

Yahoo Finance • 19 days ago

Moderna stands as the best performing large-cap healthcare stock YTD

[Heart Health Concept] Eoneren/E+ via Getty Images U.S. large-cap healthcare stocks have delivered modest year-to-date gains in 2026, holding steady into March amid its defensive appeal. Below is a list of the top 10 large-cap healthcare... Full story

Yahoo Finance • 19 days ago

S&P 500 Sinks Into Red -- These Seven Stocks Are Soaring Triple Digits

This article first appeared on GuruFocus. The S&P 500 has swung to a loss for the year as volatility, geopolitical strains and profit-taking weigh on large-cap stocks, according to market data. A review of the best-performing names with... Full story

Yahoo Finance • 22 days ago

Trump administration reportedly shortlisting CDC nominees

[Centers for disease control and prevention sign] sshepard Two physicians with somewhat contrasting views on vaccines are among the potential candidates the Trump administration is considering as its pick to lead the U.S. Centers for Dise... Full story

Yahoo Finance • 26 days ago

ISCV vs. VBR: Which Small Cap Value Approach is Right for Investors?

The Vanguard Small-Cap Value ETF (NYSEMKT:VBR) and iShares Morningstar Small-Cap Value ETF(NYSEMKT:ISCV) both target U.S. small-cap value stocks, but ISCV offers a marginally higher yield, heavier exposure to financial services, and much s... Full story

Yahoo Finance • 27 days ago

RFK Jr. dealt blow as judge blocks changes to childhood immunization schedule

[Secretary Kennedy, Health Officials Launch Mental Health And Addiction Initiative] Heather Diehl/Getty Images News A Massachusetts federal judge on Monday blocked major changes in recommendations for childhood vaccinations agreed upon by... Full story

Yahoo Finance • 27 days ago

Looking for Small-Cap Value? Consider These 2 ETFs

Key Points The iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) charges a much lower expense ratio and offers a higher dividend yield than the iShares Russell 2000 Value ETF (NYSEMKT:IWN). IWN delivered a stronger one-year return,... Full story

Yahoo Finance • 28 days ago

Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers

When veterinarians told Sydney tech entrepreneur Paul Conyngham that his rescue dog Rosie had months to live, he didn't accept the prognosis. Instead, the data scientist and machine learning engineer — with 17 years in the field but no bac... Full story

Yahoo Finance • 30 days ago

Moderna (MRNA) Declines More Than Market: Some Information for Investors

Moderna (MRNA) closed the most recent trading day at $52.56, moving -1.55% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.61% for the day. Meanwhile, the Dow lost 0.26%, and the Nasdaq,... Full story